Similar articles for PMID: 34857604

Year	Number of Results
1991	1
1992	1
1996	1
1997	1
1998	4
1999	1
2000	5
2001	2
2003	2
2004	6
2005	5
2006	3
2007	4
2008	7
2009	7
2010	4
2011	5
2012	6
2013	4
2014	5
2015	3
2016	7
2017	3
2018	5
2019	7
2020	7
2021	9
2022	14
2023	8
2024	0

1

Updated guidelines for immune thrombocytopenic purpura: Expanded management options.

DeSouza S, Angelini D. DeSouza S, et al. Cleve Clin J Med. 2021 Dec 2;88(12):664-668. doi: 10.3949/ccjm.88a.20201. Cleve Clin J Med. 2021. PMID: 34857604 Free article.

2

Treatment of immune thrombocytopenic purpura in children : current concepts.

Shad AT, Gonzalez CE, Sandler SG. Shad AT, et al. Paediatr Drugs. 2005;7(5):325-36. doi: 10.2165/00148581-200507050-00004. Paediatr Drugs. 2005. PMID: 16220997 Review.

3

Romiplostim in adults with newly diagnosed or persistent immune thrombocytopenia.

Lozano ML, Godeau B, Grainger J, Matzdorff A, Rodeghiero F, Hippenmeyer J, Kuter DJ. Lozano ML, et al. Expert Rev Hematol. 2020 Dec;13(12):1319-1332. doi: 10.1080/17474086.2020.1850253. Epub 2020 Nov 30. Expert Rev Hematol. 2020. PMID: 33249935 Review.

4

Epidemiology, pathophysiology, and initial management of chronic immune thrombocytopenic purpura.

Pruemer J. Pruemer J. Am J Health Syst Pharm. 2009 Jan 15;66(2 Suppl 2):S4-10. doi: 10.2146/ajhp080490. Am J Health Syst Pharm. 2009. PMID: 19139489

5

Retrospective analysis of rituximab therapy and splenectomy in childhood chronic and refractory immune thrombocytopenic purpura.

Ay Y, Karapinar TH, Oymak Y, Toret E, Demirag B, Ince D, Ozcan E, Moueminoglou N, Koker SA, Vergin C. Ay Y, et al. Blood Coagul Fibrinolysis. 2016 Jun;27(4):431-5. doi: 10.1097/MBC.0000000000000488. Blood Coagul Fibrinolysis. 2016. PMID: 26656905

6

First-line therapies for immune thrombocytopenic purpura: re-evaluating the need to treat.

Rodeghiero F. Rodeghiero F. Eur J Haematol Suppl. 2008 Feb;(69):19-26. doi: 10.1111/j.1600-0609.2007.01000.x. Eur J Haematol Suppl. 2008. PMID: 18211569 Review.

7

Management of adult idiopathic thrombocytopenic purpura.

Nakhoul IN, Kozuch P, Varma M. Nakhoul IN, et al. Clin Adv Hematol Oncol. 2006 Feb;4(2):136-44, 153. Clin Adv Hematol Oncol. 2006. PMID: 16728922 Review.

8

Immune thrombocytopenia.

Bussel J, Cooper N, Boccia R, Zaja F, Newland A. Bussel J, et al. Expert Rev Hematol. 2021 Nov;14(11):1013-1025. doi: 10.1080/17474086.2021.1995347. Epub 2021 Nov 18. Expert Rev Hematol. 2021. PMID: 34720027

9

Management of immune thrombocytopenic purpura in children: potential role of novel agents.

Bredlau AL, Semple JW, Segel GB. Bredlau AL, et al. Paediatr Drugs. 2011 Aug 1;13(4):213-23. doi: 10.2165/11591640-000000000-00000. Paediatr Drugs. 2011. PMID: 21692546 Review.

10

Diagnosis and management of primary immune thrombocytopenia in adults.

Ejaz A, Radia D. Ejaz A, et al. Br J Hosp Med (Lond). 2019 Apr 2;80(4):C54-C57. doi: 10.12968/hmed.2019.80.4.C54. Br J Hosp Med (Lond). 2019. PMID: 30951423 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

121 results

Results by year